Life Science News & Medical Media Coverage

Congresses

PastENDO 2026

BostonJun 13 – 16 PastEHA2026

StockholmJun 11 – 14 PastEULAR 2026

LondonJun 3 – 6 PastASCO 2026

ChicagoMay 29 – Jun 2 PastEASL Congress 2026

BarcelonaMay 27 – 30 PastENDO 2026

BostonJun 13 – 16 PastEHA2026

StockholmJun 11 – 14 PastEULAR 2026

LondonJun 3 – 6 PastASCO 2026

ChicagoMay 29 – Jun 2 PastEASL Congress 2026

BarcelonaMay 27 – 30

View all →

Rheumatology

Microbiome's Role in Lupus: A Policy and Therapeutic 'Frame Shift'Read article

Ophthalmology

New Glaucoma Care Restriction: IOP Targets and Treatment Access Read article

Oncology

Tucatinib Extends PFS in HER2-Positive Breast Cancer, No New Safety Signals Read article

Oncology

Chemoimmunotherapy Extends PFS in Metastatic Prostate Cancer Subset Read article

General Practice

Balancing Clinical Practice, Research, and Advocacy: Ruchi Gupta, MD, MPH Read article

Geriatrics21 Jun 2026

Compassion in Dementia Diagnosis: Patient Perspectives Highlighted Read article

Dentistry

Oral Ulcers and Patches: Primary Care Assessment Read article

The Life Science Feed

Podcast

Deep dives with clinicians, researchers, and industry leaders.

All episodes

NeurologyEP 3

Targeting Tau Inflammation And Alzheimer's Metabolism

Dementia Frontiers Deep Dive Series

David Mistry & Sophie Ward

23 min

NeurologyEP 2

Why New Alzheimer's Drugs Make Brains Bleed?

Dementia Frontiers Deep Dive Series

Sophie Ward & David Mistry

24 min

NeurologyEP 1

The Amyloid Hypothesis, Finally Validated?

Dementia Frontiers Deep Dive Series

Sophie Ward & David Mistry

39 min

NeurologyEP 4

Preventing 45 Percent Of Dementia Cases

Dementia Frontiers Deep Dive Series

David Mistry & Sophie Ward

26 min

550+Articles published

28Therapy areas

WeeklyClinical newsletter

FreeAlways

HighlightsView all →

Infectious Diseases

Prisons: A Missing Front in England's HIV Action Plan

England's HIV action plan overlooks prisons, a critical setting for intervention, according to a recent BMJ analysis. This omission may hinder national targets.

Oncology

Chemoimmunotherapy Extends PFS in Metastatic Prostate Cancer Subset

A chemoimmunotherapy regimen demonstrated extended progression-free survival in a specific subset of metastatic prostate cancer patients.

General Practice

Balancing Clinical Practice, Research, and Advocacy: Ruchi Gupta, MD, MPH

Ruchi Gupta, MD, MPH, exemplifies a multifaceted medical career, integrating clinical allergy and immunology with public health research and advocacy.

Gastroenterology

AI System Achieves Over 90% Accuracy in Colonoscopy Surveillance

An AI system accurately selected appropriate colonoscopy surveillance intervals in over 90% of cases, potentially streamlining post-polypectomy care.

Ophthalmology

New Glaucoma Care Restriction: IOP Targets and Treatment Access

A recent policy change limiting glaucoma treatment options warrants scrutiny, potentially impacting intraocular pressure management and patient outcomes.

Dermatology

GLP-1 Receptor Agonists and Psoriatic Disease: A Deep Dive

GLP-1 receptor agonists, primarily for type 2 diabetes and obesity, show emerging evidence for modifying psoriatic disease activity.

Pediatrics

Unintentional Injuries Remain Leading Cause of Death for 5-19 Year Olds

Unintentional injuries continue to be the primary cause of mortality among children and adolescents aged 5-19 globally, according to a recent analysis.

Endocrinology

Calorie Labelling Efficacy Varies by Socioeconomic Status

Mandatory calorie menu labelling in England shows varied impact, with greater efficacy in higher socioeconomic groups and limited effect in lower groups.

OncologyView all →

Breast Neoplasms

Genetic Test Identifies Breast Cancer Patients Who May Avoid Chemotherapy

A genetic test can identify patients with early-stage, hormone receptor-positive, HER2-negative breast cancer who may safely forgo adjuvant chemotherapy.

Breast Neoplasms

Giredestrant Improves Breast Cancer Survival Regardless of Menopause

Giredestrant, an oral selective estrogen receptor degrader (SERD), demonstrated improved invasive disease-free survival in early breast cancer.

Breast Neoplasms

Tucatinib Extends PFS in HER2-Positive Breast Cancer, No New Safety Signals

Tucatinib demonstrated extended progression-free survival in HER2-positive breast cancer with a consistent safety profile, reinforcing its role.

Prostatic Neoplasms

Alpha-Emitting Radioantibody Lowers PSA in CRPC

15 min read

Prostatic NeoplasmsASCO 2026

Biomarkers and Novel Treatments Highlight Prostate Cancer Advances at ASCO

9 min read

Prostatic Neoplasms

Chemoimmunotherapy Extends PFS in Metastatic Prostate Cancer Subset

8 min read

Solid Tumors

Combination Oncology Therapies: A Review of Efficacy and Access

7 min read

Prostatic Neoplasms

Why Not Screening for Prostate Cancer is Justified

5 min read

Pancreatic Neoplasms

Daraxonrasib Extends Overall Survival in Pancreatic Cancer

6 min read

HepatologyView all →

Fatty Liver

Metabolic Dysfunction Associated Steatotic Liver Disease: An Overview

A recent review outlines the mechanisms, diagnosis, and management of metabolic dysfunction associated steatotic liver disease (MASLD) in adults.

Fatty Liver

Liver-Directed Treatment Shows Efficacy in Metabolic Dysfunction

A novel liver-directed treatment presented at endo 2026 offers a targeted approach for metabolic dysfunction, addressing a significant unmet clinical need.

Fatty Liver

Alcohol and Sugar: A Dual Metabolic Challenge for Patients

Patients consuming alcohol and high-sugar diets face a compounded metabolic risk, impacting liver function and glucose regulation. Clinicians must address both factors.

Hepatocellular CarcinomaEASL Congress 2026

EASL Congress 2026: Key Trials to Watch in Liver Disease Management

7 min read

Portal HypertensionEASL Congress 2026

Variceal Bleeding Management: EASL 2026 Skills Centre Focuses on Endoscopic and Pharmacological Strategies

5 min read

Liver CirrhosisEASL Congress 2026

EASL 2026: Liver and Spleen Elastography for Fibrosis Assessment

6 min read

Liver CirrhosisEASL Congress 2026

EASL 2026 Forum: Enhancing Patient-Clinician Communication

6 min read

Liver CirrhosisEASL Congress 2026

EASL 2026: Alcohol Policy Action Needed for Liver Disease

7 min read

Liver CirrhosisEASL Congress 2026

A-TANGO Score Refines ACLF Diagnosis, Prognosis in Cirrhosis

6 min read

CardiologyView all →

Coronary Artery Disease

Novel Therapies Target Atherogenic Lp(a) Particle

Emerging therapeutic strategies are shifting focus from LDL cholesterol to apoB, targeting Lp(a) and other atherogenic particles.

Aortic Valve Stenosis

AI-Assisted Fetal Echocardiography Improves Early CHD Detection

Artificial intelligence (AI) integration into fetal echocardiography improves early detection of congenital heart disease (CHD), including aortic stenosis.

Myocardial Infarction

Clopidogrel and Omeprazole: Re-evaluating Concomitant Use Risk

Concomitant use of clopidogrel and omeprazole has been a clinical concern due to potential drug-drug interactions impacting clopidogrel efficacy.

Hypertension

Hypotension Linked to Increased Alzheimer's Disease Risk

7 min read

Coronary Artery Disease

Heat-Attributable CVD Years of Life Lost Projected to Rise Through 2050

5 min read

CardiomyopathiesESC Cardio-Oncology 2026

ESC Cardio-Oncology 2026: Key Sessions and Anticipated Focus Areas

5 min read

CardiomyopathiesESC Cardio-Oncology 2026

GBD 2023: Lower Respiratory Infections Remain Leading Infectious Cause of Death

5 min read

CardiomyopathiesESC Cardio-Oncology 2026

Radiotherapy and the Heart: Damage, Protection, or Treatment?

6 min read

Coronary Artery DiseaseESC Cardio-Oncology 2026

Cardiovascular Disease and Cancer: A Reciprocal Relationship

6 min read

EndocrinologyView all →

Diabetes Mellitus Type 2

Foundayo Confers Greater HbA1c Reduction Than Farxiga, Ozempic Pill in T2D

A new investigational therapy, Foundayo, demonstrated superior HbA1c reduction compared to both dapagliflozin and oral semaglutide in type 2 diabetes.

Diabetes Mellitus Type 2

Elecoglipron Oral GLP-1 Reduces Glucose, Weight in Phase 2

Elecoglipron, an investigational oral GLP-1 receptor agonist, demonstrated reductions in HbA1c and body weight in phase 2 trials.

Diabetes Mellitus Type 2

GLP-1 Receptor Agonist Use Varies Widely for Youth Type 2 Diabetes

Geographic variation in GLP-1 receptor agonist prescribing for youths with type 2 diabetes across the US highlights disparities in care.

Diabetes Mellitus Type 2

Combination GLP-1RA and SGLT2i May Offer Additive Benefits in T2DM

10 min read

Diabetes Mellitus Type 2

Omnipod 5 Improves CGM Metrics, Reduces Hypoglycaemia in Diabetes

12 min read

Osteoporosis

Bisphosphonate Interruption Reduces Fragility Fracture Risk

5 min read

Polycystic Ovary Syndrome

PMOS: Clinical Implications for Patient Management

6 min read

Diabetes Mellitus Type 2ADA 2026

Activism Essential for Scientific Freedom in ADA Controversy

7 min read

Obesity

Calorie Labelling Efficacy Varies by Socioeconomic Status

7 min read

Podcast InfographicsView all episodes →

Deep Dive · Ep 2Neurology

Why New Alzheimer's Drugs Make Brains Bleed?Download infographic

Deep Dive · Ep 1Neurology

The Amyloid Hypothesis, Finally Validated?Download infographic

Deep Dive · Ep 3Neurology

Targeting Tau Inflammation And Alzheimer's Metabolism Download infographic

Debate · Ep 4Rheumatology

Why Cheaper Humira Alternatives Face Resistance Download infographic

Debate · Ep 1Rheumatology

The ORAL Surveillance JAK Inhibitor Controversy Download infographic

NeurologyView all →

Peripheral Neuropathies

Fast Five Quiz: Assessment of Tardive Dyskinesia

This quiz addresses key aspects of tardive dyskinesia (TD) assessment, focusing on diagnostic criteria, screening, and differential diagnosis.

Alzheimer Disease

Glucosamine/Chondroitin Tied to Faster AD Progression

A recent analysis indicates that regular use of glucosamine and chondroitin may accelerate Alzheimer's disease progression in susceptible individuals.